DF
MRNA icon

DecisionPoint Financial’s Moderna MRNA Stock Holding History

DecisionPoint Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363 Buy
+5
New +$259 ﹤0.01% 740
2025
Q2 		– Sell
-31
Closed -$879 – 667
2025
Q1 		$879 Hold
31
– – ﹤0.01% 226
2024
Q4 		$1.29K Buy
+31
New +$1.48K ﹤0.01% 231

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

DecisionPoint Financial's MRNA Position: Q2 2026 in Review

DecisionPoint Financial opened a new position in Moderna (MRNA) in Q2 2026: 5 shares worth $363. The stake represents ﹤0.01% of the portfolio and ranks #740 among its holdings. This is a return to the name: DecisionPoint Financial previously reported a position in MRNA as recently as Q1 2025.

DecisionPoint Financial first reported a position in MRNA in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.29K in Q4 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • DecisionPoint Financial held 5 shares of Moderna worth $363 as of Q2 2026.
  • Moderna was a new DecisionPoint Financial position in Q2 2026.
  • Moderna made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #740 holding.
  • DecisionPoint Financial first reported a position in Moderna in Q4 2024 and has held it in 3 quarters since.
  • DecisionPoint Financial's Moderna position peaked at $1.29K in Q4 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.